Humacyte, Inc.

$HUMA is leading the Prism MarketView MedDevices index today after announcing their first sale of Symvess to a U.S. Military Treatment Facility.

Share this article:

About the Author:

Humacyte, Inc.

Joey Ramson

PRISM Market View Alerts

Get your dose of PRISM Market
View news, right in your inbox

Mailchimp Signup